BR112017020038A2 - método para inibir a oxidação de uma gordura insaturada. - Google Patents

método para inibir a oxidação de uma gordura insaturada.

Info

Publication number
BR112017020038A2
BR112017020038A2 BR112017020038A BR112017020038A BR112017020038A2 BR 112017020038 A2 BR112017020038 A2 BR 112017020038A2 BR 112017020038 A BR112017020038 A BR 112017020038A BR 112017020038 A BR112017020038 A BR 112017020038A BR 112017020038 A2 BR112017020038 A2 BR 112017020038A2
Authority
BR
Brazil
Prior art keywords
unsaturated fat
inhibiting oxidation
inhibiting
oxidation
unsaturated fats
Prior art date
Application number
BR112017020038A
Other languages
English (en)
Other versions
BR112017020038B1 (pt
Inventor
Fhaner Cassie
Joshi Kinjalbahen
Tan Yujing
Original Assignee
Dow Global Technologies Llc
Rohm & Haas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Global Technologies Llc, Rohm & Haas filed Critical Dow Global Technologies Llc
Publication of BR112017020038A2 publication Critical patent/BR112017020038A2/pt
Publication of BR112017020038B1 publication Critical patent/BR112017020038B1/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/10Washing or bathing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52Stabilizers
    • A61K2800/522Antioxidants; Radical scavengers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/347Phenols

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Cosmetics (AREA)
  • Fats And Perfumes (AREA)
  • Lubricants (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

são fornecidos métodos para inibir a oxidação de gorduras insaturadas compreendendo misturar as gorduras insaturadas com uma quantidade eficaz de um composto antioxidante de fórmula i: em que r, r1, r2, r3, r4, r5 e r6são como aqui definidos. os compostos contêm ambas as funcionalidades de nitrona e fenólica.
BR112017020038-4A 2015-03-20 2016-03-18 método para inibir a oxidação de uma gordura insaturada BR112017020038B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562136131P 2015-03-20 2015-03-20
US62/136,131 2015-03-20
PCT/US2016/023177 WO2016154018A1 (en) 2015-03-20 2016-03-18 Nitrone inhibition of oxidation of unsaturated fats

Publications (2)

Publication Number Publication Date
BR112017020038A2 true BR112017020038A2 (pt) 2018-06-05
BR112017020038B1 BR112017020038B1 (pt) 2021-03-09

Family

ID=55754405

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017020038-4A BR112017020038B1 (pt) 2015-03-20 2016-03-18 método para inibir a oxidação de uma gordura insaturada

Country Status (6)

Country Link
US (1) US10137071B2 (pt)
EP (1) EP3270876B1 (pt)
JP (1) JP6734295B2 (pt)
CN (1) CN107427430B (pt)
BR (1) BR112017020038B1 (pt)
WO (1) WO2016154018A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112016029693B1 (pt) 2014-06-30 2021-08-03 Dow Global Technologies Llc Composição para cuidado pessoal compreendendo nitronas poliméricas, e, métodos para a inibição da degradação do colágeno na pele, e para reduzir os sinais visíveis do envelhecimento
BR112017018503B1 (pt) 2015-03-20 2021-08-24 Dow Global Technologies Llc Composição de cuidados pessoais
WO2022261956A1 (en) * 2021-06-18 2022-12-22 Givaudan Sa Fragrance compounds

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5176983A (en) 1991-03-04 1993-01-05 Allied-Signal Inc. Polymeric nitrones having an acrylic backbone chain
US5273863A (en) 1991-03-04 1993-12-28 Alliedsignal Inc. Polymeric nitrones having an acrylic backbone chain
US6002001A (en) 1991-06-18 1999-12-14 Oklahoma Medical Research Foundation Spin trapping pharmaceutical compositions and methods for use thereof
CA2111836C (en) 1991-06-18 2006-08-29 John M. Carney Spin-trapping pharmaceutical compositions and methods for use thereof
US5455272A (en) 1993-10-22 1995-10-03 Oklahoma Medical Research Foundation Spin trap nitronyl hindered phenols
WO2002065993A2 (en) 2001-01-08 2002-08-29 Centaur Pharmaceuticals, Inc. Use of aryl nitrone compounds in methods for treating neuropathic pain
US6428461B1 (en) 2001-04-24 2002-08-06 Kraft Foods Holdings, Inc. Method for inhibiting oxidation of polyunsaturated lipids
DE50111204D1 (de) 2001-08-18 2006-11-23 Cognis Ip Man Gmbh Wirkstoffmischungen
DE10201223A1 (de) 2002-01-15 2003-07-24 Knut Oppenlaender Neuartige Antioxidantien für Pharma und Kosmetik auf Basis von Phenolen, Polyphenolen und natürlichen Vitaminen und Verfahren zu ihrer Herstellung
FR2846968B1 (fr) 2002-11-08 2005-02-04 Salles Jean Pierre Nouveaux derives amphiphiles de l'alpha-c-phenyl-n-tert- butyl nitrone
KR101279899B1 (ko) * 2003-10-30 2013-06-28 시바 홀딩 인코포레이티드 안정화된 바디 케어 제품, 가정용품, 직물원료 및 직물
US20050182060A1 (en) 2004-02-13 2005-08-18 Kelly Michael G. 2-Substituted and 4-substituted aryl nitrone compounds
US20050215646A1 (en) 2004-03-09 2005-09-29 Renovis, Inc. Methods for treating multiple sclerosis and pharmaceutical compositions therefor
EP1591104A1 (de) 2004-03-17 2005-11-02 Stada Arzneimittel Ag Verwendung von Antioxidantien zur Herstellung einer pharmazeutischen oder kosmetischen Zusammensetzung zum Schutz der Haut gegen Schädigung durch Infrarot-Strahlung
AU2009221634B2 (en) 2008-03-03 2014-05-08 Nad Life Pty Ltd Pharmaceutical formulations of resveratrol and methods of use thereof for treating cell disorders
ES2316312B1 (es) 2008-06-20 2010-02-08 Ignacio Umbert Millet Composicion farmaceutica dermatologica para el tratamiento de patologias de inflamacion de la piel, tales como por ejemplo dermatitis, dermatitis atopica, vitiligo, alopecia areata, acne, psoriasis y prurito,y combinaciones de las mismas.
CN102939080A (zh) 2010-04-13 2013-02-20 布莱阿姆青年大学 利用4-乙酰氧基-白藜芦醇提供增强的白藜芦醇活性的方法
JP5521788B2 (ja) 2010-05-31 2014-06-18 ユーハ味覚糖株式会社 新規なレスベラトロール重合化合物又はその薬学的に許容可能な塩
US20120058088A1 (en) 2010-06-28 2012-03-08 Resveratrol Partners, Llc Resveratrol-Containing Compositions And Methods Of Use
CN102153498B (zh) 2011-03-14 2014-04-30 暨南大学 一种白藜芦醇类似物及其制备方法和应用
CN102153449B (zh) 2011-03-15 2013-11-27 天津美科泰化工科技有限公司 煤气化粗酚的连续精制分离装置及方法
ES2391211B1 (es) 2011-05-04 2013-10-02 Select Botanical, S.L. Combinacion sinergica de polifenoles
JP6131265B2 (ja) * 2011-11-30 2017-05-17 ダウ グローバル テクノロジーズ エルエルシー ニトロン化合物とパーソナルケアにおけるその利用
US9701625B2 (en) 2014-03-07 2017-07-11 Dow Global Technologies Llc Nitrone compounds and their use in personal care
BR112016029693B1 (pt) 2014-06-30 2021-08-03 Dow Global Technologies Llc Composição para cuidado pessoal compreendendo nitronas poliméricas, e, métodos para a inibição da degradação do colágeno na pele, e para reduzir os sinais visíveis do envelhecimento

Also Published As

Publication number Publication date
US20180055749A1 (en) 2018-03-01
US10137071B2 (en) 2018-11-27
BR112017020038B1 (pt) 2021-03-09
WO2016154018A9 (en) 2017-10-05
EP3270876B1 (en) 2021-12-22
JP6734295B2 (ja) 2020-08-05
WO2016154018A1 (en) 2016-09-29
JP2018513847A (ja) 2018-05-31
CN107427430A (zh) 2017-12-01
CN107427430B (zh) 2020-12-04
EP3270876A1 (en) 2018-01-24

Similar Documents

Publication Publication Date Title
SV2018005709A (es) 3-azabiciclo[3.1.0]hexanos sustituidos como inhibidores de cetohexoquinasa
NI201700095A (es) Derivados de nucleósidos sustituidos útiles como agentes antineoplásicos
CO2018005381A2 (es) Inhibidores éster de acc y usos de los mismos
CU24615B1 (es) Compuestos para tratar afecciones asociadas con la actividad nlrp
BR112019007806A2 (pt) composição bucal de múltiplas fases para a liberação de agentes ativos para tratamento bucal
CL2018001360A1 (es) Inhibidores triazol de acc y usos de los mismos
DOP2018000268A (es) Derivados de carbonucleósidos sustituidos útiles como agentes antineoplásicos
MX2018006148A (es) Inhibidores de cxcr2.
EA201691799A1 (ru) Бициклические соединения в качестве ингибиторов продукции аутотаксина (atx) и лизофосфатидиловой кислоты (lpa)
UY35908A (es) Moduladores de tetrahidropiridopirazinas de gpr6
BR112018006696A2 (pt) métodos e sistemas para obter óleo a partir de uma composição de vinhoto
BR112015017911A2 (pt) composição aditiva antimicrobiana, composição antimicrobiana, composição antimicrobiana ou composição aditiva, método para produzir uma composição aditiva antimicrobiana, método para produzir uma composição antimicrobiana, uso de uma composição aditiva ou composição antimicrobiana
BR112016030281A8 (pt) composições, uso de uma composição, método para o combate dos fungos fitopatogênicos e sementes
CL2017002856A1 (es) Compuestos de tioéter como inhibidores de la nitrificación
EA201792604A1 (ru) Ингибиторы аутотаксина и их применения
BR112018002983A2 (pt) composição compreendendo uma lactama e um álcool
CO2018004581A2 (es) Compuestos de criptoficina y productos conjugados, y sus métodos de preparación
CR20170005A (es) Derivados de insoindolina
CL2017000484A1 (es) Compuestos de azetidiniloxifenilpirrolidina
DOP2016000120A (es) Nuevos inhibidores de dgat2
ECSP21017326A (es) Composiciones alimenticias y composiciones de aditivos para piensos para especies de acuicultura
BR112017020038A2 (pt) método para inibir a oxidação de uma gordura insaturada.
BR112017005113A2 (pt) composto de fórmula geral (i), método para preparar um composto de fórmula geral (i), método para preparar um composto de fórmula geral (iv), composição farmacêutica para o tratamento de doenças relacionadas com atividades anormais de jak3 e/ou jak1 quinase, usos do composto, e usos da composição farmacêutica
BR112017019176A2 (pt) processos para a preparação de fluorocetolídeos
BR112013010501A2 (pt) aparelho de barbear ou depilar que compreende uma composição auxiliar moldada para barbeamento ou depilação que compreende uma fonte de piritiona

Legal Events

Date Code Title Description
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 18/03/2016, OBSERVADAS AS CONDICOES LEGAIS.